公开(公告)号：US20230263866A1

公开(公告)日：2023-08-24

申请号：US17924668

申请日：2021-05-14

Applicant: JNC CORPORATION

Inventor： Nana YOKOTA ,  Tomomi NAKANO ,  Masako HINATSU ,  Jun HIRAKI ,  Hideaki FUKUSHI

IPC: A61K38/48 ,  A61P31/14 ,  A23L3/3571 ,  A23L3/3526 ,  D06M16/00 ,  D06M15/59

CPC classification number: A61K38/482 ,  A61P31/14 ,  A23L3/3571 ,  A23L3/3526 ,  D06M16/003 ,  D06M15/59

Abstract: The present invention has revealed that an antiviral agent containing a serine protease such as subtilisin, nattokinase, and trypsin has an effect of inactivating non-envelope type viruses, and that combining such an antiviral agent containing a serine protease with a cationic polymer enhances the inactivation effect of the antiviral agent against non-envelope type viruses. As a result, an antiviral agent that is highly safe, that has a high virus inactivation ability, and that contains a component that is inexpensive in terms the manufacturing cost and a cationic polymer, was discovered.